Work

Erlotinib (Tarceva®): a promising drug targeting epidermal growth factor receptor tyrosine kinase

Year: 2003

Type: article

Source: Expert Review of Anticancer Therapy

DOI: 10.1586/14737140.3.3.269

Authors: Anca M Bulgaru, Sridhar Mani, Sanjay Goel, Roman Perez-Soler

Institutions: Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2004211026

FWCI: 1.944

Cites: 36

Cited by: 48

Related to: 10